ATE429640T1 - Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort - Google Patents
Diagnostischer assay zur bestimmung einer zellvermittelten immunantwortInfo
- Publication number
- ATE429640T1 ATE429640T1 AT03769070T AT03769070T ATE429640T1 AT E429640 T1 ATE429640 T1 AT E429640T1 AT 03769070 T AT03769070 T AT 03769070T AT 03769070 T AT03769070 T AT 03769070T AT E429640 T1 ATE429640 T1 AT E429640T1
- Authority
- AT
- Austria
- Prior art keywords
- assay
- cell
- mediated immune
- immune response
- diagnostic assay
- Prior art date
Links
- 238000003556 assay Methods 0.000 abstract 5
- 239000012642 immune effector Substances 0.000 abstract 2
- 229940121354 immunomodulator Drugs 0.000 abstract 2
- 230000001404 mediated effect Effects 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Holo Graphy (AREA)
- Inspection Of Paper Currency And Valuable Securities (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002952548A AU2002952548A0 (en) | 2002-11-08 | 2002-11-08 | Diagnostic assay |
| PCT/AU2003/001464 WO2004042396A1 (en) | 2002-11-08 | 2003-11-06 | Diagnostic assay for measuring a cell mediated immune response |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE429640T1 true ATE429640T1 (de) | 2009-05-15 |
Family
ID=28795938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03769070T ATE429640T1 (de) | 2002-11-08 | 2003-11-06 | Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7608392B2 (de) |
| EP (1) | EP1561106B1 (de) |
| JP (1) | JP4502814B2 (de) |
| AT (1) | ATE429640T1 (de) |
| AU (1) | AU2002952548A0 (de) |
| CA (1) | CA2504829C (de) |
| DE (1) | DE60327354D1 (de) |
| WO (1) | WO2004042396A1 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005118884A1 (en) * | 2004-05-28 | 2005-12-15 | The United States Of America As Represented By The Secretary Of The Navy | A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines |
| JP2006189338A (ja) * | 2005-01-06 | 2006-07-20 | Sekisui Chem Co Ltd | 炎症性腸疾患の治療前効果予測方法並びに治療効果の判定方法 |
| GB0616238D0 (en) * | 2006-08-15 | 2006-09-27 | Inst Animal Health Ltd | Diagnostic Test |
| US8026076B2 (en) | 2006-09-05 | 2011-09-27 | Hvidovre Hospital | IP-10 based immunological monitoring |
| WO2008147426A2 (en) * | 2006-10-04 | 2008-12-04 | The Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
| AU2008229636B2 (en) * | 2007-03-16 | 2014-08-14 | Qiagen Sciences Llc | A cell-mediated immune response assay and kits therefor |
| WO2008128069A1 (en) * | 2007-04-11 | 2008-10-23 | Roger Deutsch | Methods for diagnosing biological samples containing stem cells |
| US20090062237A1 (en) * | 2007-06-15 | 2009-03-05 | Mayo Foundation For Medical Education And Research | Evaluating immune competence |
| WO2009035738A2 (en) * | 2007-06-15 | 2009-03-19 | University Of Rochester | Use of antibody secreting cell elispot to assess antibody responses following antigen exposure |
| EP3431987A1 (de) * | 2008-07-25 | 2019-01-23 | Cellestis Limited | Diagnoseverfahren |
| EP3269379A1 (de) | 2008-11-30 | 2018-01-17 | Immusant, Inc. | Zusammensetzungen und verfahren zur behandlung von zöliakie |
| CN102573883A (zh) | 2009-06-12 | 2012-07-11 | 疫苗技术公司 | 用于促进细胞-介导的免疫应答的方法和组合物 |
| WO2010144794A1 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Baculovirus-expressed fusion polypeptide vaccines with enhanced immunogenicity and uses thereof |
| EP2517012B1 (de) * | 2009-12-23 | 2019-05-22 | Cellestis Limited | Test zur messung von zellvermittelter immunansprechbarkeit |
| US8771967B2 (en) | 2010-11-16 | 2014-07-08 | The Board Of Trustees Of The Leland Stanford Junior University | Immunomodulation of functional T cell assays for diagnosis of infectious or autoimmune disorders |
| EP3825688A1 (de) * | 2011-04-29 | 2021-05-26 | Cellestis Limited | Testanordnung für zellvermittelte immunantworten |
| US9678071B2 (en) | 2012-01-12 | 2017-06-13 | Mayo Foundation For Medical Education And Research | Detecting latent tuberculosis infections |
| MX2014011484A (es) * | 2012-03-23 | 2015-09-23 | Esteve Labor Dr | Metodo para seguir las respuestas de celulas t especificas al vih. |
| CN102707052B (zh) * | 2012-05-11 | 2015-03-11 | 中国农业科学院北京畜牧兽医研究所 | 含重组蛋白混合物的牛结核病检测试剂 |
| ES2677723T3 (es) * | 2012-12-28 | 2018-08-06 | Cellestis Limited | Un ensayo de la respuesta inmunológica mediada por células |
| EP4272750A3 (de) | 2013-02-07 | 2024-01-24 | Children's Medical Center, Corp. | Proteinantigene zum schutz gegen pneumokokkenkolonisation und/oder -befall |
| US10401360B2 (en) | 2013-04-29 | 2019-09-03 | Mayo Foundation For Medical Education And Research | Flow cytometry assay methods |
| CA2923822A1 (en) | 2013-09-10 | 2015-03-19 | Immusant, Inc. | Dosage of a gluten peptide composition |
| CN103604933A (zh) * | 2013-11-27 | 2014-02-26 | 华中科技大学同济医学院附属同济医院 | 基于抗原特异性TNF-α-ELISA检测活动性结核病的试剂盒及其应用 |
| WO2016054038A1 (en) | 2014-09-29 | 2016-04-07 | Immusant, Inc. | Use of hla genetic status to assess or select treatment of celiac disease |
| EP3210015A1 (de) | 2014-10-23 | 2017-08-30 | Qiagen Sciences, LLC | Peptidzusammensetzung und verwendungen davon |
| US10654923B2 (en) | 2015-12-28 | 2020-05-19 | Mayo Foundation For Medical Education And Research | Methods for treating medical conditions by anti-type 2 therapy |
| KR20170110297A (ko) * | 2016-03-23 | 2017-10-11 | 온틀협동조합 | 천연물 소재의 면역증강 검사법 및 상기 검사법을 활용한 맞춤형 식단 제공방법 |
| KR101777256B1 (ko) | 2016-07-07 | 2017-09-12 | 대한민국(농림축산식품부 농림축산검역본부장) | T 세포의 병원체 감염 세포 독성능 평가 방법 |
| KR101777252B1 (ko) | 2016-07-07 | 2017-09-12 | 대한민국(농림축산식품부 농림축산검역본부장) | T 세포의 prrsv 증식 억제능 평가 방법 |
| EP3555630B1 (de) | 2016-12-14 | 2023-05-31 | Becton, Dickinson and Company | Verfahren und zusammensetzungen zum erhalt einer tuberkulosebeurteilung in einer person |
| WO2020014703A1 (en) * | 2018-07-13 | 2020-01-16 | Excision Biotherapeutics, Inc. | Detection of bacterial proteins/immunoglobulins for gene editing therapy |
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| WO2021163456A1 (en) * | 2020-02-14 | 2021-08-19 | Epivax, Inc. | T cell epitopes and related compositions useful in the prevention, diagnosis, and treatment of covid-19 |
| US20230314432A1 (en) * | 2020-07-10 | 2023-10-05 | Covid Diagnostics Ltd. | Compositions, methods, and systems for detecting immune response |
| CN113466000A (zh) * | 2021-05-12 | 2021-10-01 | 广州医科大学附属肿瘤医院 | 基于多维度纯化富集技术的恶性胸水检测方法 |
| EP4537103A4 (de) * | 2022-06-09 | 2026-06-03 | Univ California | Lymphozytenstimulationstest zur quantifizierung von immunantworten |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018653A (en) | 1971-10-29 | 1977-04-19 | U.S. Packaging Corporation | Instrument for the detection of Neisseria gonorrhoeae without culture |
| US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
| US4424279A (en) | 1982-08-12 | 1984-01-03 | Quidel | Rapid plunger immunoassay method and apparatus |
| DE3779909T2 (de) * | 1986-03-06 | 1993-01-07 | Commw Scient Ind Res Org | In-vitro-testverfahren zum nachweis zellulaerer immunresponsen. |
| FR2615622B1 (fr) * | 1987-05-19 | 1994-05-06 | Ire Medgenix Sa | Dosage plasmatique de monokines |
| US5693500A (en) * | 1988-03-31 | 1997-12-02 | Commonwealth Scientific And Industrial Research Organisation | Diagnosis of Mycobacterium bovis infection |
| FR2645878B1 (fr) * | 1989-04-17 | 1994-02-25 | Institut Nal Sante Recherc Medic | Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes |
| US6410252B1 (en) * | 1995-12-22 | 2002-06-25 | Case Western Reserve University | Methods for measuring T cell cytokines |
| US5885529A (en) * | 1996-06-28 | 1999-03-23 | Dpc Cirrus, Inc. | Automated immunoassay analyzer |
| DE19835721A1 (de) * | 1998-08-07 | 2000-02-10 | Edi Experimentelle & Diagnosti | Verfahren zur Bestimmung der Immunabwehr des Blutes sowie Testkit hierfür und Verwendung eines geeigneten Spritzenzylinders |
-
2002
- 2002-11-08 AU AU2002952548A patent/AU2002952548A0/en not_active Abandoned
-
2003
- 2003-11-06 JP JP2004548932A patent/JP4502814B2/ja not_active Expired - Lifetime
- 2003-11-06 CA CA2504829A patent/CA2504829C/en not_active Expired - Lifetime
- 2003-11-06 EP EP03769070A patent/EP1561106B1/de not_active Expired - Lifetime
- 2003-11-06 DE DE60327354T patent/DE60327354D1/de not_active Expired - Lifetime
- 2003-11-06 AT AT03769070T patent/ATE429640T1/de active
- 2003-11-06 WO PCT/AU2003/001464 patent/WO2004042396A1/en not_active Ceased
- 2003-11-06 US US10/477,571 patent/US7608392B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7608392B2 (en) | 2009-10-27 |
| JP2006506609A (ja) | 2006-02-23 |
| CA2504829C (en) | 2013-01-22 |
| EP1561106A1 (de) | 2005-08-10 |
| CA2504829A1 (en) | 2004-05-21 |
| US20050014205A1 (en) | 2005-01-20 |
| EP1561106B1 (de) | 2009-04-22 |
| JP4502814B2 (ja) | 2010-07-14 |
| AU2002952548A0 (en) | 2002-11-21 |
| DE60327354D1 (de) | 2009-06-04 |
| WO2004042396A1 (en) | 2004-05-21 |
| EP1561106A4 (de) | 2006-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60327354D1 (de) | Diagnostischer assay zur bestimmung einer zellvermittelten immunantwort | |
| IN2015DN03125A (de) | ||
| Segal et al. | Salivary diagnostics: enhancing disease detection and making medicine better | |
| TW200600055A (en) | Method of manufacturing integrated biosensors | |
| TW200600060A (en) | Apparatus for the manufacture of medical devices | |
| JP5311439B2 (ja) | 皮膚の状態を評価する方法及びその用途 | |
| DE60136335D1 (de) | Parallele genotypisierung mehrerer patientenproben | |
| GB2374929A (en) | Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart | |
| WO2000051055A3 (en) | Method and apparatus for monitoring therapy effectiveness | |
| EP2520935A3 (de) | Organspezifische Proteine und Verfahren zu deren Verwendung | |
| DE602004017201D1 (de) | Nachweis einer histonmodifikation in zellfreien nukleosomen | |
| Gupta et al. | Proteomics–the research frontier in periodontics | |
| Dewan et al. | Recent advancements and applications of nanosensors in oral health: revolutionizing diagnosis and treatment | |
| Hanås et al. | Influence of clinical setting and cat characteristics on indirectly measured blood pressure and pulse rate in healthy Birman, Norwegian Forest, and Domestic Shorthair cats | |
| ATE318930T1 (de) | Nukleinsäuresonden zur detektion von candida- spezies | |
| Radu et al. | Characteristics of haematological parameters for carp culture and Koi (Cyprinus carpio Linneaus, 1758) reared in an intensive system | |
| Cacciapuoti et al. | Effects of dietary intervention on nutritional status in elderly individuals with chronic kidney disease | |
| BRPI0406680A (pt) | Métodos para selecionar um animal para ter propriedades desejadas genotìpicas ou fenotìpicas em potencial, para modular a trascrição de mrna de um gene igf2 em uma célula ou organismo provido com referido gene e para identificar um composto, composto, composição farmacêutica, e, uso de um composto | |
| ATE352039T1 (de) | Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung | |
| DE69531505D1 (de) | Verfahren zur zellerkennung | |
| WO2010108245A3 (pt) | Uso de antígenos de leishmania em método diagnóstico, vacina e terapia para leishmaniose | |
| DE50210764D1 (de) | Testsystem zur bestimmung von gentoxizitäten | |
| Thomas | Nonhuman paleopathology | |
| Sun et al. | pawH: Colorimetric pH-Sensing Toys for Non-Invasive Pet Health Monitoring | |
| DE602006015221D1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1561106 Country of ref document: EP |